Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

MEBO - UBIOME study 2018

NCT03582826
ClinicalTrials.gov
MEBO Gut Microbiome Study
Funded by uBiome Research Grant
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 85/100
3 kits per person

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Ubiome Gut EXPLORER : 10% OFF
Join/Watch the weekly
TMAU UP Podcasts

Videos : TMAU stories

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact map@meboresearch.org
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
BannerFans.com
RESEARCH DETAILS

DONATIONS THRU 31-NOV-2016:
£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14

MEBO UK PAYPAL FOR TRINZYME

********
MEBO US PAYPAL FOR TRINZYME

Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Sunday, December 20, 2015

DMB reduces trimethylamine gut formation

From press release 
Now, the team has identified a naturally occurring inhibitor called DMB – 3,3-dimethyl-1-butanol, found in some cold-pressed extra virgin olive oils and grape seed oils – that reduced levels of TMAO and reduced atherosclerosis in mice
New TMAO paper by Dr Hazen et al at Cleveland Clinic
Their 2011 paper suggested TMA-oxide may be main cause of CVD
Since then looking for therapies
Main aim seems to have been to stop TMA formation in gut
Looks like they have been trying various candidates to stop TMA formation
This paper suggests 3,3-dimethyl-1-butanol  (DMB) inhibits TMA formation in gut
DMB is a natural compound found in certain foods and drinks
Perhaps DMB will be the compound in the OTC product they plan to sell via Proctor & Gamble
If you think TMA is the sole reason for your malodor, this could be a future therapy for 'TMAU'

TMA inhibited by DMB research : link to full paper
Cleveland Clinic official press release : link
UK Daily Mail article : link
Prof Colin Dolphin comment : link  

In 2011 Dr Stan Hazen et al at the Cleveland Clinic first put forward the hypothesis that TMA-oxide may be a strong (perhaps strongest) biomarker for CVD. Since then it seems they have been looking at ways to deal with this. It seems their main aim was to stop trimethylamine formation in the gut. It looks like they have been looking at many compounds that may do this, and have now published of finding a compound, 3,3-dimethyl-1-butanol (DMB), which naturally occurs in some foods and drinks, which seems to inhibit TMA formation in the gut (e.g blocks/interferes with the choline to TMA process created by enzymes in gut bacteria).

It is not clear if this discovery is at an advanced stage or if they have just proved the concept and that DMB may not even be the ideal compound. We do know they signed an agreement with Proctor and Gamble in August to produce an #over the counter' product in the future that will help with 'TMAO management'.

So at the moment we know little other than they have proved the concept of blocking/reducing TMA formation in the gut, but will have to wait to see what happens next. Obviouisly if it blocks TMA formation then it should be a therapy for TMAU too (if you feel that TMA is the sole compound causing your malodor). With the therapy meant for Heart disease and perhaps other seriouos metabolic disorders, we can assume a lot of money has gone into this research and probably will in the future.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

2 comments:

Anonymous said...

Thank you for posting, this is very interesting. Hopefully it can benefit us in the near future

Dec 24, 2015, 7:51:00 AM
kelly carroll said...

I don't know which parent I inherited this condition from. I do know that my dad died from cvd at 75. This cold be the reason. I wish I was a scientist so that I could help find a cure. Every time I buy a lottery ticket I think to myself...please God let me win so I can donate to rare disease issues. FIRSTLY a cure for us tmau sufferers. Secondly everything else. That is all I ask.

Jan 18, 2016, 10:42:00 PM
Post a Comment